KBC Group’s Orthofix Medical OFIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-1,804
Closed -$23K 1898
2023
Q3
$23K Sell
1,804
-1,075
-37% -$19.3K ﹤0.01% 1863
2023
Q2
$52K Hold
2,879
﹤0.01% 1360
2023
Q1
$48K Buy
2,879
+1,340
+87% +$26.2K ﹤0.01% 1394
2022
Q4
$32K Hold
1,539
﹤0.01% 1470
2022
Q3
$29K Hold
1,539
﹤0.01% 1479
2022
Q2
$36K Buy
+1,539
New +$44.1K ﹤0.01% 1478
2019
Q1
Sell
-10,275
Closed -$539K 1427
2018
Q4
$539K Sell
10,275
-18,240
-64% -$1.04M 0.01% 913
2018
Q3
$1.65M Buy
28,515
+4,810
+20% +$270K 0.01% 755
2018
Q2
$1.35M Sell
23,705
-3,494
-13% -$199K 0.01% 716
2018
Q1
$1.6M Hold
27,199
0.01% 633
2017
Q4
$1.49M Hold
27,199
0.01% 664
2017
Q3
$1.28M Sell
27,199
-9,377
-26% -$442K 0.01% 724
2017
Q2
$1.7M Buy
36,576
+9,471
+35% +$393K 0.02% 632
2017
Q1
$1.03M Buy
27,105
+8,593
+46% +$318K 0.01% 858
2016
Q4
$670K Buy
18,512
+5,690
+44% +$216K 0.01% 965
2016
Q3
$548K Buy
+12,822
New +$572K 0.01% 937

Other funds holding OFIX

KBC Group's OFIX Position: Q4 2023 in Review

KBC Group sold out of Orthofix Medical (OFIX) in Q4 2023, closing a stake of 1,804 shares — an estimated $23K sold.

KBC Group first reported a position in OFIX in Q3 2016 and held it in 16 quarters. The position peaked at $1.7M in Q2 2017. 156 funds tracked by Wall St. Rank hold OFIX as of Q4 2023.

  • KBC Group reported no remaining Orthofix Medical position as of Q4 2023 after selling out during the quarter.
  • KBC Group sold 1,804 Orthofix Medical shares in Q4 2023, an estimated $23K.
  • KBC Group first reported a position in Orthofix Medical in Q3 2016 and held it in 16 quarters.
  • KBC Group's Orthofix Medical position peaked at $1.7M in Q2 2017.
  • 156 funds tracked by Wall St. Rank held Orthofix Medical as of Q4 2023.

Based on KBC Group's 13F filing for Q4 2023, filed 13 Feb 2024.